查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1737093

全球 COVID-19检测套组市场规模（按样本类型、检测类型、产品类型、最终用途、地区和预测）

Global COVID-19 Testing Kits Market Size By Sample Type (Nasopharyngeal Swab Oropharyngeal Swab, Nasal Swab), By Test Type (Molecular Testing, Antigen-based Testing), By Product Type, By End-Use, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

COVID-19检测套组市场规模及预测

2024 年 COVID-19检测套组市场规模为 73.132 亿美元，预计到 2032 年将达到 26.688 亿美元，2026 年至 2032 年的复合年增长率为 13.06%。

COVID-19 检测套件用于 SARS-CoV-2 的试管内诊断和鑑定。这些套件可在几分钟到几小时内快速提供结果，有助于对患者照护。

在预测期内，改善患者照护、持续的技术进步以及对 COVID-19 检测套件的需求增加可能会推动市场扩张。

由于大多数国家的大多数人口都接种了疫苗，新的 COVID-19 病例数量正在下降，这可能会阻碍未来几年的市场成长。

大多数国家正在透过设立免下车或步行检测中心来增加检测地点的数量。

这些检测中心将减少医护人员的等待时间，并降低感染风险。对于冠状病毒的识别，在家采集样本的技术已成为更安全的选择。

这些因素的相互作用带来了供不应求和检测地点有限的挑战。

COVID-19检测套组的全球市场动态

影响全球 COVID-19检测套组市场的关键市场动态包括：

关键驱动因素

全球大流行：COVID-19 的迅速蔓延增加了进行大规模检测以有效识别、隔离和治疗病例的需求。

政府措施：世界各地的许多政府都要求定期进行检测，从而推动了整个医疗保健系统和产业检测套组的需求。

技术进步：根据世界卫生组织（WHO）的数据，截至2024年，全球已发现100多种SARS-CoV-2变异株。根据美国疾病管制与预防中心（CDC）的报告，2021年美国，即Omicron变异株出现之时，美国平均每天进行160万次检测，比2021年10月增加了300%。 RT-PCR、快速抗原和抗体检测等检测方法的创新提高了准确性并缩短了检测时间。

提高意识：人们对早期检测和预防的认识不断提高，这使得大众需要能够轻鬆获得的检测套组。

商业和旅行限制：旅行、职场和活动必须进行检测，这增加了对检测套组的需求。

主要挑战

供应链中断：全球原料短缺和製造瓶颈导致检测套组的生产和分发延迟。

准确性和可靠性问题：一些快速检测因与黄金标准 RT-PCR 检测相比准确性较低而受到批评。

不断进化的病毒株：COVID-19 新变种的出现引发了人们对检测准确性和对抗突变有效性的担忧。

检测成本高：频繁检测，尤其是在低收入地区，对大规模、持续的检测构成了经济挑战。

竞争和产能过剩：大量公司涌入市场，导致价格波动和对品管的担忧。

主要趋势

家用检测套组：对于可在家中方便进行的自我检测套组的需求显着增加。

快速检测：快速抗原检测因能在几分钟内提供结果而广受欢迎，是旅行或活动现场检测的理想选择。

即时诊断：专为诊所或即时诊断而设计的检测套组无需复杂的实验室设备即可进行快速诊断。

与数位平台整合：许多检测套组将与行动应用程式和数位平台集成，以便追踪、验证和报告结果。

专注于具有成本效益的解决方案：越来越多的公司正在开发低成本的测试解决方案，以便新兴国家和服务不足地区能够使用它们。

目录

第一章 全球COVID-19检测套组市场简介

  • 市场概览
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章 COVID-19检测套组全球市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

5. 全球 COVID-19检测套组市场（依样本类型）

  • 概述
  • 鼻咽拭子
  • 口咽拭子
  • 鼻拭子
  • 其他的

6. 全球 COVID-19检测套组市场（依检测类型）

  • 概述
  • 分子（PCR）检测
  • 基于抗原的检测
  • 抗体（血清学）检测
  • 其他的

7. 全球 COVID-19检测套组市场（依最终用途）

  • 概述
  • 研究所
  • 医院
  • 诊断中心和诊所
  • 研究所

8. 全球 COVID-19检测套组市场（依产品类型）

  • 概述
  • 试剂和套件
  • 检测设备
  • 服务

9. 全球 COVID-19检测套组市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区
    • 拉丁美洲
    • 中东和非洲

第十章全球COVID-19检测套组市场竞争格局

  • 概述
  • 各公司市场排名
  • 主要发展策略

第十一章 公司简介

  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • PerkinElmer, Inc.
  • drop, Inc.
  • Veredus Laboratories
  • Altona Diagnostics GmbH（ADT Biotech Sdn Bhd）
  • BioFire Diagnostics
  • Co-Diagnostics, Inc
  • GenMark Diagnostics, Inc.
  • BGI
  • Qiagen
  • Randox Laboratories Ltd
  • SD Biosensor

第十二章 附录

    • 相关报告
简介目录
Product Code: 50257

COVID-19 Testing Kits Market Size And Forecast

COVID-19 Testing Kits Market size was valued at USD 7313.2 Million in 2024 and is projected to reach USD 2668.8 Million by 2032, growing at a CAGR of 13.06% from 2026 to 2032.

The COVID-19 detection kits are used to diagnose and identify SARS-CoV-2 in vitro. These kits deliver quicker results in a matter of minutes or hours, assisting in proper patient care.

Improved patient care, ongoing technical advancements, and increased demand for COVID-19 detection kits will drive market expansion over the forecast period.

Most people in most countries are vaccinated, and the number of new COVID-19 infections is declining. Such a factor will hinder market growth in the approaching years.

The majority of countries have increased the number of testing locations by establishing drive-through and walk-through testing centers.

These testing centers shorten wait times and lower the risk of infection among healthcare workers. For the identification of the coronavirus, at-home sample collection techniques have emerged as a substantially safer option.

The intersection of these factors tackles the difficulties of a supply shortage and a limited amount of testing locations.

The majority of countries have increased the number of testing locations by establishing drive-through and walk-through testing centers.

These testing centers shorten wait times and lower the risk of infection among healthcare workers. For the identification of the coronavirus, at-home sample collection techniques have emerged as a substantially safer option.

The intersection of these factors tackles the difficulties of a supply shortage and a limited number of testing locations.

Global Covid-19 Testing Kits Market Dynamics

The key market dynamics that are shaping the global COVID-19 testing kits market include:

Key Drivers

Global Pandemic: The rapid spread of COVID-19 increased the need for mass testing to identify, isolate, and treat cases effectively.

Government Initiatives: Many governments worldwide mandated regular testing, driving demand for testing kits across healthcare systems and industries.

Technological Advancements: According to the World Health Organization (WHO), as of 2024, over 100 SARS-CoV-2 variants have been identified globally. The Centers for Disease Control and Prevention (CDC) reports that during the emergence of the Omicron variant, the U.S. conducted an average of 1.6 million tests per day in December 2021, a 300% increase from October 2021. Innovations in testing methods like RT-PCR, rapid antigen, and antibody tests improved accuracy and reduced testing time.

Rising Awareness: Increased awareness about early detection and prevention fueled the need for accessible testing kits for the general population.

Corporate and Travel Regulations: Mandatory testing for travel, workplaces, and events sustained demand for testing kits.

Key Challenges

Supply Chain Disruptions: Global shortages of raw materials and manufacturing bottlenecks created delays in test kit production and distribution.

Accuracy and Reliability Issues: Some rapid tests faced criticism over lower accuracy rates compared to gold-standard RT-PCR tests.

Evolving Virus Strains: The emergence of new COVID-19 variants led to concerns about test accuracy and effectiveness against mutations.

High Cost of Testing: Frequent testing, especially in low-income regions, posed affordability challenges for large-scale, continuous testing.

Competition and Overproduction: The rapid influx of players into the market caused price fluctuations and concerns about quality control.

Key Trends

At-Home Testing Kits: There was a significant rise in demand for self-testing kits, enabling convenient testing from home.

Rapid Testing: Rapid antigen tests gained popularity due to their ability to deliver results within minutes, ideal for on-the-spot testing in travel and events.

Point-of-Care Diagnostics: Testing kits designed for use in clinics and at point-of-care settings enabled quicker diagnostics without needing complex lab equipment.

Integration with Digital Platforms: Many testing kits are integrated with mobile apps and digital platforms for result tracking, verification, and reporting.

Focus on Cost-Effective Solutions: Companies increasingly developed low-cost testing solutions to ensure accessibility in developing countries and underserved regions.

Global Covid-19 Testing Kits Market Regional Analysis

Here is a more detailed regional analysis of the global COVID-19 testing kits market:

Asia Pacific

The Asia Pacific region has experienced significant growth in the Global COVID-19 Testing Kits Market, driven by rising infection rates and the urgent need for rapid and accurate testing solutions.

Governments across countries such as India, China, Japan, and Australia have implemented extensive testing protocols to contain the virus's spread, resulting in increased demand for various types of testing kits, including PCR, rapid antigen, and antibody tests.

The region's robust manufacturing capabilities have allowed local companies to scale up production and meet the surging demand for testing kits.

Collaborations between governments, healthcare organizations, and private companies have facilitated research and development efforts to enhance the accuracy and efficiency of testing solutions.

Increased public awareness about the importance of testing and monitoring COVID-19 infections has further propelled market growth.

As vaccination rates rise and the focus shifts toward managing the pandemic, the demand for COVID-19 testing kits is expected to evolve, with an emphasis on at-home testing and innovative technologies such as digital health platforms.

The Asia Pacific region is poised to play a crucial role in shaping the future of the COVID-19 testing kits market through continued innovation and collaboration.

North America

North America, is anticipated to witness the fastest growth in the Global COVID-19 Testing Kits Market during the forecast period driven by the urgent need for widespread testing during the pandemic.

The U.S. Department of Health and Human Services invested $785 million in 2024 to improve COVID-19 testing access for vulnerable and high-risk populations.

According to a survey by the College of American Pathologists, 72% of medical laboratories have expanded their molecular testing capabilities since 2020, with COVID-19 testing representing an average of 30% of their molecular diagnostics workload.

The U.S. Bureau of Labor Statistics projects a 7% growth in clinical laboratory technologist and technician jobs from 2021 to 2032, partly driven by continued COVID-19 testing demands.

The United States and Canada implemented aggressive testing strategies to manage the virus's spread, leading to increased demand for various testing kits, including PCR, rapid antigen, and antibody tests.

The U.S. Food and Drug Administration (FDA) played a crucial role in accelerating the approval process for testing kits, allowing manufacturers to bring their products to market quickly.

This expedited regulatory environment fostered innovation and competition among companies, resulting in a diverse range of testing solutions that cater to different needs, from laboratory-based tests to at-home testing kits.

Partnerships between public health agencies, research institutions, and private companies have enhanced the development and distribution of testing kits.

The region has also witnessed significant investments in research and development, aimed at improving the accuracy and efficiency of COVID-19 testing methods.

Global COVID-19 Testing Kits Market: Segmentation Analysis

The Global COVID-19 Testing Kits Market is Segmented based on Sample Type, Test Type, Product Type, End-Use, and Geography.

COVID-19 Testing Kits Market, By Sample Type

  • Nasopharyngeal (NP) Swab
  • Oropharyngeal (OP) Swab
  • Nasal Swab

Based on sample type, the Global COVID-19 Testing Kits Market is segmented into Nasopharyngeal (NP) Swabs, Oropharyngeal (OP) Swabs, and Nasal Swabs. The Nasopharyngeal (NP) Swab segment holds a significant share in the market owing to its high accuracy and widespread use in detecting viral infections. The Oropharyngeal (OP) Swab and Nasal Swab segments are also vital in diagnostic processes, providing alternatives in sample collection methods to accommodate patient comfort and clinical needs.

COVID-19 Testing Kits Market, By Test Type

  • Molecular (PCR) Testing
  • Antigen-based Testing
  • Antibody (Serology) Testing

Based on test type, the Global COVID-19 Testing Kits Market is segmented into Molecular (PCR) Testing, Antigen-based Testing, and Antibody (Serology) Testing. The Molecular (PCR) Testing segment dominates the Global COVID-19 Testing Kits Market owing to its high accuracy in detecting active infections by identifying the virus's genetic material.

COVID-19 Testing Kits Market, By Product Type

  • Reagents & Kits
  • Instruments
  • Service

Based on product type, the Global COVID-19 Testing Kits Market is segmented into Reagents & Kits, Instruments, and Services. The Reagents & Kits segment holds a significant share of the Global COVID-19 Testing Kits Market, driven by the need for mass testing to curb the spread of the virus.

COVID-19 Testing Kits Market, By End-Use

  • Laboratories, Hospitals
  • Diagnostic Centers and Clinics,
  • Research Institutes

Based on end-use, the global COVID-19 testing kits market is segmented into Laboratories, Hospitals, Diagnostic Centers and Clinics, and Research Institutes. The Laboratories and Hospitals segment dominates in the Global COVID-19 Testing Kits Market owing to the large-scale testing and treatment of COVID-19 patients in medical facilities.

COVID-19 Testing Kits Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on geography, the global COVID-19 testing kits market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific region has experienced significant growth in the Global COVID-19 Testing Kits Market, driven by rising infection rates and the urgent need for rapid and accurate testing solutions. Governments across countries such as India, China, Japan, and Australia have implemented extensive testing protocols to contain the virus's spread, resulting in increased demand for various types of testing kits, including PCR, rapid antigen, and antibody tests. The region's robust manufacturing capabilities have allowed local companies to scale up production and meet the surging demand for testing kits.

Key Players

The "Global COVID-19 Testing Kits Market" study report provides valuable insight with an emphasis on the global market. The major players in the market are Hoffmann-La Roche AG, Abbott Laboratories, Thermo Fisher Scientific, Inc., PerkinElmer, Inc., 1drop, Inc., Veredus Laboratories, Altona Diagnostics GmbH (ADT Biotech Sdn Bhd), BGI, Cepheid BioFire Diagnostics, Co-Diagnostics, Inc, GenMark Diagnostics, Inc., Qiagen, Randox Laboratories Ltd, SD Biosensor.

  • This section offers in-depth analysis through a company overview, position analysis, the regional and industrial footprint of the company, and the ACE matrix for insightful competitive analysis. The section also provides an exhaustive analysis of the financial performances of mentioned players in the given market.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Covid-19 Testing Kits Market Key Developments

  • In July 2020, Mylab Discovery Solutions made the Pathocatch COVID-19 antigen fast testing kit available, developed in collaboration with LabCare Diagnostics, a Gujarat-based company. As a result of this progress, the company improved its market position.
  • In February 2021, Thermo Fisher Scientific announced the launch of the CE-IVD-Marked TaqPath COVID-19 HT Kit, a COVID-19 diagnostic assay compatible with the Amplitude platform, designed for high throughput and reliable, accurate testing. This product launch aided the corporation in gaining market share.

TABLE OF CONTENTS

1 INTRODUCTION TO THE GLOBAL COVID19 TESTING KITS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL COVID19 TESTING KITS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porter Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL COVID19 TESTING KITS MARKET, BY SAMPLE TYPE

  • 5.1 Overview
  • 5.2 Nasopharyngeal (NP) Swab
  • 5.3 Oropharyngeal (OP) Swab
  • 5.4 Nasal Swab
  • 5.5 Others

6 GLOBAL COVID19 TESTING KITS MARKET, BY TEST TYPE

  • 6.1 Overview
  • 6.2 Molecular (PCR) Testing
  • 6.3 Antigen-based Testing
  • 6.4 Antibody (Serology) Testing
  • 6.5 Others

7 GLOBAL COVID19 TESTING KITS MARKET, BY END-USE

  • 7.1 Overview
  • 7.2 Laboratories
  • 7.3 Hospitals
  • 7.4 Diagnostic Centers and Clinics
  • 7.5 Research Institutes

8 GLOBAL COVID19 TESTING KITS MARKET, BY PRODUCT TYPE

  • 8.1 Overview
  • 8.2 Reagents & Kits
  • 8.3 Instruments
  • 8.4 Service

9 GLOBAL COVID19 TESTING KITS MARKET, BY GEOGRAPHY

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 The U.S.
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 The U.K.
    • 9.3.3 France
    • 9.3.4 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Rest of Asia Pacific
  • 9.5 Rest of the World
    • 9.5.1 Latin America
    • 9.5.2 Middle East and Africa

10 GLOBAL COVID19 TESTING KITS MARKET COMPETITIVE LANDSCAPE

  • 10.1 Overview
  • 10.2 Company Market Ranking
  • 10.3 Key Development Strategies

11 COMPANY PROFILES

  • 11.1 F. Hoffmann-La Roche AG
    • 11.1.1 Overview
    • 11.1.2 Financial Performance
    • 11.1.3 Product Outlook
    • 11.1.4 Key Developments
  • 11.2 Abbott Laboratories
    • 11.2.1 Overview
    • 11.2.2 Financial Performance
    • 11.2.3 Product Outlook
    • 11.2.4 Key Developments
  • 11.3 Thermo Fisher Scientific, Inc.
    • 11.3.1 Overview
    • 11.3.2 Financial Performance
    • 11.3.3 Product Outlook
    • 11.3.4 Key Developments
  • 11.4 PerkinElmer, Inc.
    • 11.4.1 Overview
    • 11.4.2 Financial Performance
    • 11.4.3 Product Outlook
    • 11.4.4 Key Developments
  • 11.51drop, Inc.
    • 11.5.1 Overview
    • 11.5.2 Financial Performance
    • 11.5.3 Product Outlook
    • 11.5.4 Key Developments
  • 11.6 Veredus Laboratories
    • 11.6.1 Overview
    • 11.6.2 Financial Performance
    • 11.6.3 Product Outlook
    • 11.6.4 Key Developments
  • 11.7 Altona Diagnostics GmbH (ADT Biotech Sdn Bhd)
    • 11.7.1 Overview
    • 11.7.2 Financial Performance
    • 11.7.3 Product Outlook
    • 11.7.4 Key Developments
  • 11.8 BioFire Diagnostics
    • 11.8.1 Overview
    • 11.8.2 Financial Performance
    • 11.8.3 Product Outlook
    • 11.8.4 Key Developments
  • 11.9 Co-Diagnostics, Inc
    • 11.9.1 Overview
    • 11.9.2 Financial Performance
    • 11.9.3 Product Outlook
    • 11.9.4 Key Developments
  • 11.10 GenMark Diagnostics, Inc.
    • 11.10.1 Overview
    • 11.10.2 Financial Performance
    • 11.10.3 Product Outlook
    • 11.10.4 Key Developments
  • 11.11 BGI
    • 11.11.1 Overview
    • 11.11.2 Financial Performance
    • 11.11.3 Product Outlook
    • 11.11.4 Key Developments
  • 11.12 Qiagen
    • 11.12.1 Overview
    • 11.12.2 Financial Performance
    • 11.12.3 Product Outlook
    • 11.12.4 Key Developments
  • 11.13 Randox Laboratories Ltd
    • 11.13.1 Overview
    • 11.13.2 Financial Performance
    • 11.13.3 Product Outlook
    • 11.13.4 Key Developments
  • 11.14 SD Biosensor
    • 11.14.1 Overview
    • 11.14.2 Financial Performance
    • 11.14.3 Product Outlook
    • 11.14.4 Key Developments

12 Appendix

    • 12.1.1 Related Reports